Atai Life Sciences Total Liabilities and Share Holders Equity 2020-2024 | ATAI
Atai Life Sciences total liabilities and share holders equity from 2020 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Atai Life Sciences Annual Total Liabilities and Share Holders Equity (Millions of US $) |
2023 |
$293 |
2022 |
$305 |
2021 |
$414 |
2020 |
$112 |
2019 |
$62 |
Atai Life Sciences Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
2024-06-30 |
$216 |
2024-03-31 |
$269 |
2023-12-31 |
$293 |
2023-09-30 |
$308 |
2023-06-30 |
$254 |
2023-03-31 |
$281 |
2022-12-31 |
$305 |
2022-09-30 |
$343 |
2022-06-30 |
$349 |
2022-03-31 |
$384 |
2021-12-31 |
$414 |
2021-09-30 |
$484 |
2021-06-30 |
$506 |
2021-03-31 |
$145 |
2020-12-31 |
$112 |
2020-09-30 |
$0 |
2020-06-30 |
$0 |
2020-03-31 |
$0 |
2019-12-31 |
$62 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Outpatient & Home Care |
$0.265B |
$0.000B |
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|